![Addition of Darbepoetin Alfa to Dose-Dense Chemotherapy: Results From a Randomized Phase II Trial in Small-Cell Lung Cancer Patients Receiving Carboplatin Plus Etoposide - Clinical Lung Cancer Addition of Darbepoetin Alfa to Dose-Dense Chemotherapy: Results From a Randomized Phase II Trial in Small-Cell Lung Cancer Patients Receiving Carboplatin Plus Etoposide - Clinical Lung Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/918257/6698465/gr1.jpg)
Addition of Darbepoetin Alfa to Dose-Dense Chemotherapy: Results From a Randomized Phase II Trial in Small-Cell Lung Cancer Patients Receiving Carboplatin Plus Etoposide - Clinical Lung Cancer
![Frontiers | Darbepoetin Alfa in Young Infants With Renal Failure: Single Center Experience, a Case Series and Review of the Literature Frontiers | Darbepoetin Alfa in Young Infants With Renal Failure: Single Center Experience, a Case Series and Review of the Literature](https://www.frontiersin.org/files/Articles/415627/fped-06-00398-HTML/image_m/fped-06-00398-t002.jpg)
Frontiers | Darbepoetin Alfa in Young Infants With Renal Failure: Single Center Experience, a Case Series and Review of the Literature
![PDF] Dose equivalence between continuous erythropoietin receptor activator (CERA), Darbepoetin and Epoetin in patients with advanced chronic kidney disease. | Semantic Scholar PDF] Dose equivalence between continuous erythropoietin receptor activator (CERA), Darbepoetin and Epoetin in patients with advanced chronic kidney disease. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a43dfdedbb0b141c7477cec9b71802d834e22060/2-Table1-1.png)
PDF] Dose equivalence between continuous erythropoietin receptor activator (CERA), Darbepoetin and Epoetin in patients with advanced chronic kidney disease. | Semantic Scholar
![Switching from Weekly to Every-other-week Darbepoetin Alfa Administration Maintains Hemoglobin Levels in Peritoneal Dialysis | Nefrología Switching from Weekly to Every-other-week Darbepoetin Alfa Administration Maintains Hemoglobin Levels in Peritoneal Dialysis | Nefrología](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/X2013251409004924:20418078_t1_p139.jpg?idApp=UINPBA000064)
Switching from Weekly to Every-other-week Darbepoetin Alfa Administration Maintains Hemoglobin Levels in Peritoneal Dialysis | Nefrología
![Efficacy and Safety of Daprodustat Compared with Darbepoetin Alfa in Japanese Hemodialysis Patients with Anemia | American Society of Nephrology Efficacy and Safety of Daprodustat Compared with Darbepoetin Alfa in Japanese Hemodialysis Patients with Anemia | American Society of Nephrology](https://cjasn.asnjournals.org/content/clinjasn/15/8/1155/F1.large.jpg)
Efficacy and Safety of Daprodustat Compared with Darbepoetin Alfa in Japanese Hemodialysis Patients with Anemia | American Society of Nephrology
Conversion from Epoetin Alfa to Darbepoetin Alfa: Effects on Patients' Hemoglobin and Costs to Canadian Dialysis Centres
![PDF] Dose-Conversion Ratio for Epoetin Alfa and Darbepoetin Alfa in Chemotherapy Patients with Anemia and Cancer | Semantic Scholar PDF] Dose-Conversion Ratio for Epoetin Alfa and Darbepoetin Alfa in Chemotherapy Patients with Anemia and Cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9dcc30c0903acb07ca0222d47923a2c4e79dfe42/2-Table1-1.png)
PDF] Dose-Conversion Ratio for Epoetin Alfa and Darbepoetin Alfa in Chemotherapy Patients with Anemia and Cancer | Semantic Scholar
![These highlights do not include all the information needed to use ARANESP safely and effectively. See full prescribing information for ARANESP . ARANESP ® (darbepoetin alfa ) i njection, for intravenous or These highlights do not include all the information needed to use ARANESP safely and effectively. See full prescribing information for ARANESP . ARANESP ® (darbepoetin alfa ) i njection, for intravenous or](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=aranesp-2f.jpg&id=643587)
These highlights do not include all the information needed to use ARANESP safely and effectively. See full prescribing information for ARANESP . ARANESP ® (darbepoetin alfa ) i njection, for intravenous or
![These highlights do not include all the information needed to use ARANESP safely and effectively. See full prescribing information for ARANESP . ARANESP ® (darbepoetin alfa ) i njection, for intravenous or These highlights do not include all the information needed to use ARANESP safely and effectively. See full prescribing information for ARANESP . ARANESP ® (darbepoetin alfa ) i njection, for intravenous or](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=aranesp-26.jpg&id=643587)
These highlights do not include all the information needed to use ARANESP safely and effectively. See full prescribing information for ARANESP . ARANESP ® (darbepoetin alfa ) i njection, for intravenous or
![Aranesp Hematopoietic Agent Darbepoetin Alfa in Polysorbate Solution 100 mcg / mL Subcutaneous or Intravenous Injection Single Dose Vial 1 mL - Suprememed Aranesp Hematopoietic Agent Darbepoetin Alfa in Polysorbate Solution 100 mcg / mL Subcutaneous or Intravenous Injection Single Dose Vial 1 mL - Suprememed](https://www.suprememed.com/wp-content/uploads/2022/02/aranesphematopoieticagentdarbepoetinamg55513000504-595x595.jpg)